Related Experiment Videos
[Retinopathy of prematurity]
C Jandeck1, U Kellner, M H Foerster
1Universitätsaugenklinik Charité - Universitätsmedizin Berlin, Berlin. claudia.jandeck@charite.de
Klinische Monatsblatter Fur Augenheilkunde
|March 31, 2004
Summary
Retinopathy of prematurity (ROP) remains a significant concern despite advances in neonatal care. Early ophthalmologic screening and timely laser treatment for advanced ROP are crucial for preventing blindness in premature infants.
Area of Science:
- Ophthalmology
- Neonatology
- Pediatric Medicine
Context:
- Premature infants face significant risks for vision impairment, particularly retinopathy of prematurity (ROP).
- Advances in neonatal intensive care have increased survival rates of extremely premature infants, but ROP incidence remains high.
- ROP is a leading cause of preventable childhood blindness globally.
Purpose:
- To review current knowledge and recent clinical advances in retinopathy of prematurity (ROP).
- To discuss the pathophysiology, classification, and epidemiology of ROP.
- To summarize treatment strategies, outcomes, and future therapeutic options for ROP.
Summary:
- This review covers the history, classification, and pathophysiology of ROP.
- It summarizes findings from multicenter treatment trials and discusses current screening guidelines (German and international).
- Therapeutic strategies, treatment outcomes, and potential future therapies like anti-angiogenic factors are explored.
Impact:
- Highlights the importance of timely ophthalmologic screening and laser treatment in preventing ROP-related blindness.
- Addresses the long-term ophthalmologic sequelae in preterm infants, including amblyopia, strabismus, and refractive errors.
- Informs clinical practice and research directions for managing and potentially preventing retinopathy of prematurity.